Keyword: cancer

News

AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4 Billion

25.03.2024 -

AstraZeneca has agreed to acquire Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

Chemistry & Life Sciences

The Future of mRNA Technology

20.03.2024 -

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...

News

Large-Scale Production Announced by Epsilogen and Lonza for Ovarian Cancer Treatment

05.03.2024 -

Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...

News

Moderna and Immatics Collaborate on Cancer Therapies

18.09.2023 -

US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies...

Chemistry & Life Sciences

The Success Story of Biosimilars

13.09.2023 -

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...

News

Gilead Partners with Tentarix on Cancer and Inflammation Therapies

17.08.2023 -

Gilead Sciences and Tentarix Biotherapeutics established three multi-year collaborations using Tentarix’s proprietary Tentacles platform to discover and develop multi...

News

Bayer and Bicycle in Cancer Collaboration

16.05.2023 -

Bayer and UK biotech Bicycle Therapeutics have agreed to collaborate to develop and commercialize the latter’s radioconjugates for multiple oncology targets.

News

BioNTech and DualityBio Sign ADC Rights Deal

14.04.2023 -

German biotech and Covid vaccine maker BioNTech has sealed a major deal with Chinese biotech DualityBio to co-develop and commercialize two cancer antibody drug...